Skip to main content
OpenTrials
Completed

NCT Number: NCT06377943

The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females

This Study is focused on the interaction between resting metabolic rate (RMR), physical activity (PA), and thyroid hormones (TH). TH controls almost all the cell activities of the body so, it is known as one of the major regulatory hormones. This is the reason for individuals who suffer from thyroid disorders show abnormal metabolism. Recently it was suggested that interindividual variations in thyroid hormone levels also influence daily physical activity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

Shenzhen, Guangdong, 518000, China

About this study

In this study, investigators will recruit adult females with a BMI ≥18.5. After the screening process, eligible volunteers will undergo certain measurements including body composition, resting metabolism daily physical activity, thyroid hormone levels, and total energy expenditure. The investigators will access the changes in resting metabolism and daily physical activities with the differences in thyroid hormone levels.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female age ≥18;
  • BMI≥18.5

Exclusion criteria

  • Intended weight change exceeding 2kg within the past three months;
  • Having any special medical diets or having eating disorders;
  • Pregnant women or breastfeeding women;
  • People who have metal implants in their bodies;
  • Patients with metabolic diseases, infectious diseases, and genetic disorders such as hypothyroidism, and hyperthyroidism;
  • Patients with a personal or family history of medullary thyroid carcinoma (MTC), or patients with rare type 2 multiple endocrine tumor syndrome (MEN2); People with a fear of needles (Trypanophobia), claustrophobia; People who are fear of blood (Hemophobia) or pathological hypotension;

Treatment and study plan

Primary outcomes

  1. Body weight

    Time frame: Measurements will take at the first day of the visit

    Subjects will be asked to fast overnight and weight will be measured using a calibrated Seca body weight scale first thing in the morning on subjects wearing light clothes and no shoes.

  2. Height

    Time frame: Measurements will take at the first day of the visit

    Measured by seca 217 stable stadiometer. Subjects wearing no shoes.

  3. Waist and Hip circumferences

    Time frame: Measurements will take at the first day of the visit

    Waist and Hip circumferences will be measured using a whole body laser scanner.

  4. Fat mass

    Time frame: Measurements will take at the first day of the visit

    Fat mass will be measured by Magnetic Resonance Imaging (Shanghai united imaging, uMR 790 ) or DXA (Hologic).

  5. Far free mass

    Time frame: Measurements will take at the first day of the visit

    Fat free mass will be measured by Bioimpedance Analysis (Tanita, MC-980) or DXA (Hologic).

  6. Bone mass

    Time frame: Measurements will take at the first day of the visit

    Bone mass will be measured by DXA (Hologic).

  7. Resting Metabolism

    Time frame: Measurements will take at the first day of the visit.

    Resting energy expenditure will be measured using indirect calorimetry via a respiratory hood system (Cosmed). The subject attends the lab after an overnight fast. The person lies down on a flatbed and the hood is placed over their head. Metabolic rates (oxygen consumption and CO2 production) are monitored for 30 minutes. Calorimeters will be assessed with a turbine test to ensure the accuracy of measurements. Validation via an alcohol burn will be performed monthly.

  8. Physical activity

    Time frame: Measurements last for 14 days

    Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 14 days. The monitor should not be worn while bathing or swimming. The first day is discarded along with any day where the wear time is less than 10 hours. For a valid measure, the goal is to get at least 2 weekday and 2 weekend days.

  9. Thyroid hormone

    Time frame: Blood samples will collect at the first day of the visit.

    Nurses will collect the blood samples on day 1. Levels of circulating thyroid hormones will be measured using radio immunoassay.

  10. Resting Metabolism

    Time frame: measurements will take at the first day of visit

    The whole room calorimeter/metabolic chamber (OMNICAL, Maastricht instrument) will be used to measure resting metabolic rate. The metabolic chamber is a sealed room with a continuous gas supply (CO2- 0.80×10-2, O2 -18.00×10-2), providing subjects with 24-hour energy expenditure data. The total energy expenditure of the subjects in MJ/day was plotted against time in 30-minute intervals over 24 hours. The lowest and most stable energy expenditure during sleep time was considered the RMR of the subjects, which occurred from 2:00 am to 5:00 am.

Secondary outcomes

  1. Total energy expenditure

    Time frame: Measurements take for 14 days

    Total energy expenditure (TEE) will be measured using the DLW method. Urine samples from all participants in the DLW subset will be stored at -20 oC and analyzed in the laboratory of Dr. John Speakman at the Shenzhen Institute of Advanced Technology, Chinese Academy of sciences. Isotopes will be measured in a benchtop near-infrared isotope gas analyzer, and mean CO2 production will be calculated from isotope ratios using the recently derived equation (Speakman et al 2021: Cell reports medicine). TEE will then be calculated using mean CO2 production using the Weir equation.

  2. Total energy expenditure

    Time frame: Measurements take at the first day of the visit

    Total energy expenditure will be measured using the whole room calorimeter / metabolic chamber (OMNICAL, Maastricht instrument). The metabolic chamber is a sealed room with a continuous gas supply (CO2- 0.80×10-2, O2 -18.00×10-2), providing subjects with 24-hour energy expenditure data. The total energy expenditure was calculated by averaging the chamber's gaseous exchange using a 24-hour time window between 11.30 am and the next day around 3.00 pm.

Sponsors and collaborators

Lead sponsor

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Apr 22, 2024
Registry last updated
Aug 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.